Targeting the Fanconi Anemia/Brca Pathway Circumvents Drug Resistance in Multiple Myeloma

Cancer Research - United States
doi 10.1158/0008-5472.can-09-2616
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Regulation of DNA Cross-Link Repair by the Fanconi Anemia/Brca Pathway

Genes and Development
GeneticsDevelopmental Biology
2012English

Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Targeting Fanconi Anemia/Brca2 Pathway Defects in Cancer: The Significance of Preclinical Pharmacogenomic Models

Clinical Cancer Research
Cancer ResearchOncology
2007English

Drug Inhibition Profile Prediction for NFκB Pathway in Multiple Myeloma

PLoS ONE
Multidisciplinary
2011English

Expanded Roles of the Fanconi Anemia Pathway in Preserving Genomic Stability

Genes and Development
GeneticsDevelopmental Biology
2010English

Mechanisms of Drug Resistance in Relapse and Refractory Multiple Myeloma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

Cooperation of the ATM and Fanconi Anemia/Brca Pathways in Double-Strand Break End Resection

Cell Reports
BiochemistryGeneticsMolecular Biology
2020English

Fanconi Anemia

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Targeting the Pim Kinases in Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy